Eli Lilly and Company (LLY)
XDUS
Real-time Data
06:00 AM
Day's Range
1,076.2052 wk Range
593.90Overview - LLY - Eli Lilly and Company
Key Statistics
Valuation
Enterprise Value
35.23B
P/E (Trailing)
‪46.77‬
PEG Ratio
‪1.77‬
Price / Book
‪28.30‬
EV / EBITDA
‪1.00‬
Profitability
Gross Margin
‪85.77%‬
Profit Margin
‪83.04%‬
Operating Margin
‪45.56%‬
Return on Assets
‪18.35%‬
Return on Equity
‪77.78%‬
Ownership
Shares Outstanding
891.50M
Price stats
50-Day Avg
‪1,023.75‬
200-Day Avg
‪907.51‬
Dividends
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - LLY - Eli Lilly and Company
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on XDUS.
- LLYXDUSEli Lilly and Company+43.08%52-week change46.79P/E (Trailing)‪83.04%‬Profit Margin
- BAYAXDUSBayer AG Sponsored ADR+42.50%52-week change-13.04P/E (Trailing)‪58.75%‬Profit Margin
- 6MKXDUSMerck & Co., Inc.+41.66%52-week change17.34P/E (Trailing)‪74.80%‬Profit Margin
- IDPXDUSBiogen Inc.+35.99%52-week change21.13P/E (Trailing)‪75.69%‬Profit Margin
- JNJXDUSJohnson & Johnson+33.91%52-week change20.83P/E (Trailing)‪67.87%‬Profit Margin
- JNJ0XDUSJohnson & Johnson CDR+32.38%52-week change19.41P/E (Trailing)‪67.87%‬Profit Margin
- 7XPXDUSOrganon & Co.+31.76%52-week change16.18P/E (Trailing)‪53.29%‬Profit Margin
Profile Summary - LLY - Eli Lilly and Company
About
Eli Lilly and Company is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. Headquartered in Indianapolis, Indiana, the company focuses on therapies addressing diabetes, oncology, immunology, neuroscience, and cardiometabolic conditions. Its portfolio includes…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
